Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Isabella, Radice"'
Autor:
Lucio Tremolizzo, Isabella Radice, Elisa Salvati, D Grana, Carlo Ferrarese, Fulvio Da Re, Chiara Zoia, Francesca Re, Maria Gregori, Massimo Masserini, Elisa Conti
Publikováno v:
Neurochemistry International. 108:60-65
The accumulation of extracellular amyloid beta (Abeta42) both in brain and in cerebral vessels characterizes Alzheimer's disease (AD) pathogenesis. Recently, the possibility to functionalize nanoparticles (NPs) surface with Abeta42 binding molecules,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87e073d1341648a54c4fd73667bf6c4e
https://doi.org/10.1016/j.neuint.2017.02.012
https://doi.org/10.1016/j.neuint.2017.02.012
Autor:
Angelo Aliprandi, Marta Elena Santarone, Carlo Ferrarese, Ildebrando Appollonio, Chiara Zoia, Isabella Radice, Marco Casati, Lucio Tremolizzo, Roberto Dominici, Andrea Salmaggi, Elisa Conti, M. Tironi
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 31:296-303
Objective Donepezil (DNPZ) is a drug commonly used for Alzheimer's disease (AD) that may favour a T helper 2 phenotype leading to increased naturally occurring auto-antibodies (NAb) against beta-amyloid (Aβ). We hypothesized the involvement of the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bae136740f49045b671fa0bb61b4377
https://doi.org/10.1002/hup.2538
https://doi.org/10.1002/hup.2538
Autor:
Andrea Menegon, Vania Broccoli, Giulia Regalia, Angelo Iannielli, Cinzia Cancellieri, Claudia Di Berardino, Mirko Luoni, Isabella Radice, Giovanna Lazzari, Stefano Taverna, Serena Giannelli, Alicia Rubio
Publikováno v:
Scientific Reports
The CRISPR/Cas9 system is a rapid and customizable tool for gene editing in mammalian cells. In particular, this approach has widely opened new opportunities for genetic studies in neurological disease. Human neurons can be differentiated in vitro fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf50d71d969724631a93840f97cf684b
https://doi.org/10.1038/srep37540
https://doi.org/10.1038/srep37540
Autor:
Elisa, Conti, Lucio, Tremolizzo, Marta Elena, Santarone, Marco, Tironi, Isabella, Radice, Chiara Paola, Zoia, Angelo, Aliprandi, Andrea, Salmaggi, Roberto, Dominici, Marco, Casati, Ildebrando, Appollonio, Carlo, Ferrarese
Objective: Donepezil (DNPZ) is a drug commonly used for Alzheimer's disease (AD) that may favour a T helper 2 phenotype leading to increased naturally occurring auto-antibodies (NAb) against beta-amyloid (Aβ). We hypothesized the involvement of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6ffc33b073e4dc5ff7a24bc1d1b97c87
http://hdl.handle.net/10281/127465
http://hdl.handle.net/10281/127465
